In Compliance with the Provisions of the SEBI ( Prohibition of Insider Trading) Regulations, 2015 & the Company''s code of Internal Procedure and conduct for regulating , monitoring and ....
Awaiting price reaction for this filing.
Blueblood Ventures has informed BSE that its Board of Directors will meet on Thursday, May 29, 2025, at its registered office in Greater Kailash-II, New Delhi. The key item on the agenda is the approval of the Audited Standalone Financial Results for the half year and full financial year ended March 31, 2025. As per SEBI's Insider Trading Regulations, the trading window for designated persons and insiders has been closed since March 31, 2025, and will reopen on May 30, 2025. No actual financial numbers or audit observations have been disclosed in this filing — it is purely a pre-results intimation.
This is a routine regulatory filing with no direct impact on shareholders. Investors should watch for the actual audited results expected on or after May 29, 2025, which could influence stock sentiment depending on the company's FY25 performance.